A silent mutation affects pain perception?

Earlier this week you probably read the whole saga of how researchers tracked down some individuals who could not sense pain. They then identified the gene responsible as SCN9A, a voltage-gated sodium channel and that was published in Nature. But in Science there was another report of a gene, Catechol-O-Methyltransferase (S-COMT), that is critical for pain perception ...

Well it turns out that the data in the Science paper is much more interesting than the flashy (yet uninsightful) observations of individuals walking on hot coal and receiving knife stabs into their arms without even flinching. Here are the mutations in the S-COMT gene:

one located in the S-COMT promoter region (A/G; rs6269) and three in the S- and MB-COMT coding region at codons his62his (C/T; rs4633), leu136leu (C/G; rs4818), and val158met (A/G; rs4680)

Yes 3 of the mutants are SILENT mutations (and the fourth is in the promoter). In other words the translation product is not altered at the amino acid level. So what is the problem? Expression level perhaps? Here's what the researchers have to say about the most interesting mutation:

i-bf885e46f3d87e3c202c10f6370c13d9-S-COMT.gif

[tissue culture neurons expressing the APS mutant form of S-COMT] displayed a moderate 2.5- and 3-fold reduction in enzymatic activity for S- and MB-COMT constructs, respectively, while protein expression levels did not differ.

Silent mutation => no change in protein LEVEL??? => change in protein activity??????

The authors hypothesize that the major defect is ... mRNA secondary structure. The mRNA secondary structure affects either mRNA stability or translation efficiency as in the HPS mutant (see pic), but in the APS mutant form? Protein thermostability.

The moderate reduction in enzymatic activity produced by the APS haplotype is most likely due to the previously reported decrease in protein thermostability coded by the met158 allele.

In other words, the silent mutation (and thus mRNA structure) is affecting protein folding. Very interesting hypothesis. mRNA secondary structure could slow down the ribosome at certain points along the transcript and thus affects the kinetics of co-translational folding. In other words, perhaps a substable protein-fold is formed during synthesis, but for it form you need to stall the ribosome. This same fold could be inhibited by parts of the protein that are made subsequently - thus if you allow folding befor making the rest of the protein, you're OK. Make the protein too fast and the substable-fold can't form properly.

Unfortunately they don't have great proof for this idea. I guess you could perform NMR or get an X-ray structure of the two forms. But for all those researchers who model protein folding, take notice! And for the rest ... again from the paper:

Our data have very broad evolutionary and medical implications for the analysis of variants common in the human population. The fact that alterations in mRNA secondary structure resulting from synonymous changes have such a pronounced effect on the level of protein expression emphasizes the critical role of synonymous nucleotide positions in maintaining mRNA secondary structure and suggests that the mRNA secondary structure, rather than independent nucleotides in the synonymous positions, should undergo substantial selective pressure (22).

Ref:
A. G. Nackley, S. A. Shabalina, I. E. Tchivileva, K. Satterfield, O. Korchynskyi, S. S. Makarov, W. Maixner, L. Diatchenko
Human Catechol-O-Methyltransferase Haplotypes Modulate Protein Expression by Altering mRNA Secondary Structure
Science (2006) 314:1930 - 1933

More like this

MDR: Multi Drug Resistance Protein. It's an ABC (ATPase Box Cassette) Transporter. In other words, this gene encodes an energy utilizing pump that sits on the plasma membrane and actively transports (mostly hydrophobic?) compounds out of the cell. As I wrote yesterday, a silent change in this gene…
Pim van Meurs has a blog post at The Panda's Thumb about the recent paper on translational selection on a synonymous polymorphic site in a eukaryotic gene (DOI link). He points out that this was predicted in a paper from 1987. In short, the rate of translation depends on the tRNA pool -- amino…
As we all know, the genetic code is redundant. Within protein coding regions, substitutions at silent sites do not affect the amino acid sequence of the encoded protein. Because of this property, these synonymous substitutions (so-called because they result in the same amino acid) are often used to…
Just read this Abstract from PLoS: Mammalian genes are highly heterogeneous with respect to their nucleotide composition, but the functional consequences of this heterogeneity are not clear. In the previous studies, weak positive or negative correlations have been found between the silent-site…

There was also a very recent paper in Science or Nature demonstrating that a hereditary inability to sense pain in some families in India is caused by missense mutations in a particular voltage-gated sodium channel subunit (I *think* Nav1.7, but I could be wrong.)

By PhysioProf (not verified) on 23 Dec 2006 #permalink

Thanks for that. Incredibly I had glanced at the paper you mentioned and then a couple of minutes later saw this paper. I got the intro of one confused with the other ... duh.

From the Science paper:

COMT is an enzyme responsible for degrading catecholamines and thus represents a critical component of homeostasis maintenance (3). The human COMT gene encodes two distinct proteins: soluble COMT (S-COMT) and membrane-bound COMT (MB-COMT) through the use of alternative translation initiation sites and promoters (3). Recently, COMT has been implicated in the modulation of persistent pain (47). Our group demonstrated that three common haplotypes of the human COMT gene are associated with pain sensitivity and the likelihood of developing temporomandibular joint disorder (TMJD), a common chronic musculoskeletal pain condition (4).